Rekah Pharmaceutical Industry Ltd. (REKA.TA)
ILA 1400.0
(0.43%)
ILA 1400.0
(0.43%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 28.35 Million | 39 Million | 21.16 Million | 11.28 Million | 33.91 Million | 17.28 Million |
| Net Income | -6.91 Million | -2.04 Million | 6.61 Million | 10.79 Million | 3.86 Million | 6.82 Million |
| Depreciation & Amortization | 29.83 Million | 27.48 Million | 22.85 Million | 19.71 Million | 16.9 Million | 10.75 Million |
| Deferred income taxes | - | - | -1.55 Million | 143 Thousand | - | - |
| Stock-based compensation | 191 Thousand | 397 Thousand | 445 Thousand | 95 Thousand | - | - |
| Change in working capital | 6.93 Million | 7.89 Million | -7.49 Million | -19.81 Million | 13.98 Million | -1.23 Million |
| Other non-cash items | -1.7 Million | 5.27 Million | 297 Thousand | 347 Thousand | -840 Thousand | 935 Thousand |
| Investing Cash Flow | -21.49 Million | -13.44 Million | -35.9 Million | -18.74 Million | -44.63 Million | -14.81 Million |
| Investments in PPE | -11.48 Million | -7.48 Million | -13.99 Million | -18.83 Million | -45.39 Million | -15.17 Million |
| Acquisitions | -9.78 Million | -6 Million | -22.03 Million | - | 546 Thousand | -434 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -223 Thousand | 33 Thousand | 128 Thousand | 91 Thousand | 218 Thousand | 797 Thousand |
| Financing Cash Flow | -7.78 Million | -24.35 Million | -2.77 Million | 19.08 Million | 5.84 Million | 3.56 Million |
| Debt repayment | -2.26 Million | -18.95 Million | -38.02 Million | -20.95 Million | -23.14 Million | -14.58 Million |
| Dividends payments | - | -10 Million | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -10.04 Million | 4.59 Million | 35.24 Million | 40.03 Million | 28.98 Million | 18.15 Million |
| Accounts receivables | 6.79 Million | -14.56 Million | -14.4 Million | -10.2 Million | -3.94 Million | 9.28 Million |
| Accounts payables | - | 14.56 Million | 14.4 Million | 10.2 Million | 3.94 Million | - |
| Inventory | 2.9 Million | -2.58 Million | 13.18 Million | -28.66 Million | 13.44 Million | -6.83 Million |
| Other working capital | -2.77 Million | 10.48 Million | -20.67 Million | 8.85 Million | 541 Thousand | 5.6 Million |
| Cash at beginning of period | 20.2 Million | 18.6 Million | 36.89 Million | 25.56 Million | 31.66 Million | 24.98 Million |
| Cash at end of period | 19.31 Million | 20.2 Million | 18.6 Million | 36.89 Million | 25.56 Million | 31.69 Million |
| Capital Expenditure | -11.48 Million | -7.48 Million | -13.99 Million | -18.83 Million | -45.39 Million | -15.17 Million |
| Effect of forex changes on cash | 34 Thousand | 408 Thousand | -780 Thousand | -298 Thousand | -1.24 Million | 664 Thousand |
| Net cash flow / Change in cash | -898 Thousand | 1.6 Million | -18.29 Million | 11.32 Million | -6.09 Million | 6.7 Million |
| Free Cash Flow | 16.86 Million | 31.52 Million | 7.17 Million | -7.55 Million | -11.48 Million | 2.1 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 11.99 Million | 1.2 Million | -901 Thousand | -6.91 Million | -5.49 Million | -1.09 Million |
| Depreciation & Amortization | 8.39 Million | 8.06 Million | 7.73 Million | 29.83 Million | 7.73 Million | 7.42 Million |
| Deferred income taxes | - | - | - | - | 43 Thousand | -162 Thousand |
| Stock-based compensation | 34 Thousand | -43 Thousand | 40 Thousand | 191 Thousand | 50 Thousand | 51 Thousand |
| Change in working capital | 19.02 Million | -2.38 Million | -7.4 Million | 6.93 Million | -9.91 Million | 21.09 Million |
| Other non-cash items | 193 Thousand | 402 Thousand | 10.92 Million | -1.7 Million | 384 Thousand | 441 Thousand |
| Investing Cash Flow | 22.25 Million | -2.91 Million | -3.17 Million | -21.49 Million | -4.56 Million | -12.04 Million |
| Investments in PPE | -1.33 Million | -3.03 Million | -3.14 Million | -11.48 Million | -4.4 Million | -2.35 Million |
| Acquisitions | - | - | - | -9.78 Million | -188 Thousand | -9.78 Million |
| Investment purchases | - | - | - | - | - | 88 Thousand |
| Sales/Maturities of investments | 1000.00 | 115 Thousand | - | - | - | 76 Thousand |
| Other Investing Activities | 23.58 Million | 113 Thousand | -32 Thousand | -223 Thousand | 35 Thousand | -64 Thousand |
| Financing Cash Flow | -42.22 Million | -12 Million | -1.76 Million | -7.78 Million | 972 Thousand | -12.71 Million |
| Debt repayment | -40.82 Million | -9.51 Million | -7.67 Million | -2.26 Million | -7.34 Million | -10.83 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -496 Thousand | -654 Thousand | -9.43 Million | -10.04 Million | 8.31 Million | -1.88 Million |
| Accounts receivables | 17.99 Million | -8.8 Million | -1.72 Million | 6.79 Million | 9.54 Million | 2.19 Million |
| Accounts payables | - | - | - | - | -9.54 Million | -2.19 Million |
| Inventory | -2.33 Million | -436 Thousand | -5.1 Million | 2.9 Million | 3.49 Million | 3.67 Million |
| Other working capital | 3.35 Million | -188 Thousand | -571 Thousand | -2.77 Million | -13.41 Million | 17.41 Million |
| Cash at beginning of period | 11.03 Million | 19.31 Million | 13.99 Million | 20.2 Million | 24.73 Million | 21.7 Million |
| Cash at end of period | 5.41 Million | 11.03 Million | 19.31 Million | 19.31 Million | 13.99 Million | 24.73 Million |
| Capital Expenditure | -1.33 Million | -3.03 Million | -3.14 Million | -11.48 Million | -4.4 Million | -2.35 Million |
| Effect of forex changes on cash | 28 Thousand | 17 Thousand | -139 Thousand | 34 Thousand | 50 Thousand | 45 Thousand |
| Net cash flow / Change in cash | -5.62 Million | -8.27 Million | 5.31 Million | -898 Thousand | -10.73 Million | 3.03 Million |
| Free Cash Flow | 12.98 Million | 3.59 Million | 7.25 Million | 16.86 Million | -11.6 Million | 25.39 Million |
0K5R
AME
AMCR
TTT
YEXT
MACF